News

Officers and First Responders Monitor Stress for Health Prevention

Everyday, first responders put their own lives at risk to help individuals, families, and communities. They experience frontline tragical issues, such as accidents, deaths, murders, etc. In Canada, according to the Tema Conter Memorial Trust, ‘’PTSD, Post Traumatic Stress Disorder, is a very real phenomenon facing over 20% of all First Responders’’ (CASP, 2016).


Health data are useful to get insights about the individual’s vitals. Hexoskin provides the physiological data, which gives an easy access to the vital signs information in order to determine the appropriate prevention solutions. Hexoskin can measure and report in real-time, high-level actionable data such as readiness information;  remote dashboard for command center; focus and cognitive assessment; stress and fatigue monitoring; mood status monitoring; energy expenditure and metabolism monitoring.

View full article →

Hexoskin, a non-invasive system, used to monitor sleep and save costs

As seen in the AARP document, The Longevity Economy – How People Over 50 are Driving Economic and Social Value in the U.S., ‘’early experiments also indicate that Hexoskin may facilitate remote monitoring/telehealth—in uses ranging from ambient assisted living (AAL) to sleep health (Banejee, T. et al., 2015) (…) This reduces both public and individual healthcare costs, and is minimally intrusive for patients.’’

 



Hexoskin is the only clinically validated system that continuously 
records ECG with respiratory lung functions and daily/sleep activities. It is used more and more to assess sleep quality at home and in clinical studies. In fact, all the data recorded with Hexoskin are important to consider when it comes to wellness and longevity.

Here is the link to the AARP document: The Longevity Economy

-----------------------------------------------------------------------------------------------------------------------------------------


Sleep disorders can have a dramatic impact on a person's health. According to the American College of Cardiology, obstructive sleep apnea affects more than 12 millions American adults which most of the time aren't diagnosed. The relationship between sleep disorders and cardiovascular diseases is well documented.

Hexoskin presents its research at SLEEP 2017 in Boston (June 3-7)

Hexoskin is going to attend the SLEEP 2017 conference next week June 3-7 in Boston. Dr. Roger Godbout, professor at the University of Montreal and researcher at Hospital Rivières-des-Prairies, is going to present the results of a sleep monitoring clinical trial we've done with his research lab.

Hexoskin has been involved in clinical research and sleep analysis algorithm development since 2012. Researchers and professionals love how easy it is to access physiological data with Hexoskin.

Here's the link to the program for SLEEP 2017: Conference official program.

We will be presenting at the session “O01: Circadian Rhythms, Activity, and Sleep Assessment” on Sunday, June 4th, 2017 from 1:00 PM - 3:00 PM in collaboration with Dr. Roger Godbout. We are scheduled to present from 2:45 PM - 3:00 PM.

 

Hexoskin smart shirts measure the quantity and quality of your sleep and are used for long-term sleep evaluation at home. Hexoskin is not a medical device. The monitoring system is used for clinical research and performance training. Hexoskin smart shirts are compatible with Android and iOS devices.

Link to our Sleep page: Monitoring your sleep with Hexoskin

Hexoskin demonstrates its connected health platform at DPharm in Boston

This week Hexoskin is in Boston to attend the 3rd Annual Mobile in Clinical Trials on September 19th and the 6th annual DPharm: Disruptive Innovations to Advance Clinical Trials on September 20-21, 2016 in Boston. This annual event sponsored by Hexoskin is an opportunity for the Life Science industry to share the latest thinking, insights, and updates on the application of disruptive and mobile technologies to advance clinical research and drug development.

On September 20th, Pierre-Alexandre Fournier, CEO and Co-Founder of Hexoskin will present how clinical grade wearable sensors like Hexoskin is used for long-term remote monitoring in clinical trials. He will also share with the participants some use cases involving Hexoskin for monitoring patients in clinical research, and share lessons learned & best practices.

Additionally, Hexoskin will demonstrate its technology in the exhibition hall of the conference on September 20-21st (booth #35). The Hexoskin team will present how Hexoskin can be used in clinical development with live demos and presentations.

We're very excited to join world-class innovators at DPharm to discuss and reflect on how disruptive technologies like Hexoskin will change the landscape of clinical trials.

If you're in Boston come visit us on September 20-21st!

September 19, 2016: Mobile in Clinical Trials (Boston)

September 20-21, 2016: DPharm (Boston) - Disruptive Innovation to Advance Clinical Trials Conference

About Hexoskin
Hexoskin is the world leader in smart clothing for health monitoring. Hexoskin smart shirts are used by space and defense agencies, sports scientists, and thousands of health professionals and health researchers all over the world, providing a new, convenient way to understand human health in real-life environments. For more information, visit www.hexoskin.com and @Hexoskin on Twitter.

Hexoskin connected health architecture

Researchers, Get the Most out of Hexoskin Data

Wondering how you can turn Hexoskin data into ready-to-publish graphs? 

You're in luck, Hexoskin is announcing its compatibility with VivoSense, the most comprehensive physiological data analysis software available for health research and clinical studies. It allows researchers and scientists to import and export data, execute batch processing, and produce meaningful and ready-to-publish graphs of study results.

VivoSense's 400+ customers include organizations like the Mayo Clinic, the Massachusetts General Hospital, MIT, and US Army and Air Force research labs. VivoSense is a validated platform and is 21 CFR Part 11 compliant and specifically designed for use in clinical trials and research studies. 

VivoSense core software and modules are available from Hexoskin today.

Check out How to Manage and Publish Hexoskin Data